Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지
DOI QR코드

DOI QR Code

The Palliative Care and Hospice for the People Living with HIV

HIV 감염인을 위한 완화의료와 호스피스

  • Choi, Jae-Phil (Division of Infectious Diseases, Department of Internal Medicine, Seoul Medical Center)
  • Received : 2017.08.04
  • Accepted : 2017.08.07
  • Published : 2017.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

According to the advance of antiretroviral regimen and the early treatment strategy, people living with human immunodeficiency virus (PLWH) are achieving the goal of virologic suppression and immune restoration. Most of them no more die of acquired immunodeficiency syndrome (AIDS) defining illnesses, and become older with chronic comorbidities such as cardiovascular, metabolic, hepatic, renal and neurological diseases. However some PLWH still visit hospitals as late presenters with very low CD4+ T cell counts, so that they suffer AIDS defining illnesses to die or experience severe neurological complications resulting in disabilities. Early palliative interventions are needed on the various symptoms of PLWH. Thus far chronic pains such as distal symmetric sensory polyneuropathies have been underevaluated. Active pain-relieving interventions are important to them. Recently we define end of life condition of human immunodeficiency virus (HIV) or eligibility to hospice care after adjusting current status of HIV treatment. Hospice teams should pay attention to the specific medical conditions, psychological needs, and social circumstances of PLWH. With just standard precautions as common infection control measures, general hospice cares can be provided to them like to other hospices subjects. For giving PLWH opportunities to have the end of life with value and dignity, hospice multidisciplinary team should intervene them early and aggressively. Now we need more clinical experiences and institutional improvements.

항레트로바이러스제 치료의 확립, 조기치료로 HIV 감염인들의 바이러스의 조절과 면역저하의 개선이 이루어지고 있다. 다수의 환자들이 더 이상 에이즈 관련 합병증으로 사망하지 않고, 심혈관질환, 대사성질환, 간질환, 신장질환, 신경계질환과 같은 만성합병질환을 갖고 고령화되고 있다. 그러나 지금도 여전히 사회적 차별과 낙인이 존재하는 가운데 후기 발현자로 후천면역결핍증 상태로 방문하여 사망하거나 중증의 신경계합병증으로 장애를 갖는 환자들이 있다. 환자의 다양한 증상들에 대해 이른 시기부터의 완화의료적 접근이 필요하다. 원위 대칭성 감각 다발신경병증 등의 환자의 만성 통증은 저평가되어 왔고 이에 대한 적극적인 통증 중재가 필요하다. 이전 호스피스 기준은 현재 시점에서 새롭게 제시한다. 감염인의 약제 지속 등의 의학적 필요, 심리적 상태, 사회적 여건에 대한 이해가 필요하다. 표준주의 감염관리 원칙을 준수한다면 만성질환으로서의 보편적 호스피스 진료의 제공이 가능하겠다. 생의 말기 빠르고 적극적인 호스피스팀의 개입을 통해 환자들이 존엄하게 삶을 마무리하실 수 있도록 임상경험이 늘어나고, 제도가 마련되길 바란다.

Keywords

References

  1. Centers for Disease Control (CDC). Pneumocystis pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-2.
  2. Centers for Disease Control (CDC). Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR Morb Mortal Wkly Rep 1981;30: 305-8.
  3. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71. https://doi.org/10.1126/science.6189183
  4. Selwyn PA, Arnold R. From fate to tragedy: the changing meanings of life, death, and AIDS. Ann Intern Med 1998;129: 899-902. https://doi.org/10.7326/0003-4819-129-11_Part_1-199812010-00012
  5. United States. Department of Health and Human Services; Centers for Disease Control and Prevention (U.S.); Panel on Clinical Practices for the Treatment of HIV Infection (U.S.). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [Internet]. [Atlanta, GA]: [U.S. Dept. of Health and Human Services, Centers for Diseases Control and Prevention (CDC)]; 2016. Available from: https://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL003412.pdf.
  6. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015;373:795-807. https://doi.org/10.1056/NEJMoa1506816
  7. TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med 2015;373:808-22. https://doi.org/10.1056/NEJMoa1507198
  8. Kim SW. Non-AIDS morbidity among HIV patients. Korean J Med 2016;90:487-93. https://doi.org/10.3904/kjm.2016.90.6.487
  9. Centers for Disease Control & Prevention. 2017 HIV/AIDS control guidelines [Internet]. Cheongju: Centers for Disease Control & Prevention; 2016. Available from: https://www.cdc.go.kr/CDC/cms/content/mobile/81/72281_view.html.
  10. UNAIDS. UNAIDS DATA 2017 [Internet]. Geneva: UNAIDS; c2017. Available from: http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf.
  11. Costagliola D. Demographics of HIV and aging. Curr Opin HIV AIDS 2014;9:294-301. https://doi.org/10.1097/COH.0000000000000076
  12. Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, et al. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013. J Infect 2016;72:587-96. https://doi.org/10.1016/j.jinf.2016.01.017
  13. National Human Rights Commission of Korea. 2017 Medical discrimination survey on people living with HIV/AIDS. Seoul: National Human Rights Commission of Korea;2016.
  14. Stewart A, Chan Carusone S, To K, Schaefer-McDaniel N, Halman M, Grimes R. Causes of Death in HIV Patients and the Evolution of an AIDS Hospice: 1988-2008. AIDS Res Treat 2012;2012:390406.
  15. Selwyn PA, Rivard M. Palliative care for AIDS: challenges and opportunities in the era of highly active anti-retroviral therapy. J Palliat Med 2003;6:475-87. https://doi.org/10.1089/109662103322144853
  16. Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther 2016;13:35. https://doi.org/10.1186/s12981-016-0120-0
  17. Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS 2008;22 Suppl 2:S67-79.
  18. Pressian.com [Internet]. AIDS patients can not go to any hospitals. Who are responsible? Seoul: Pressian Coop.; 2016 Jan 30. Available from: http://www.pressian.com/news/article.html?no=132875.
  19. Yennurajalingam S, Bruera E. Oxford American handbook of hospice and palliative medicine and supportive care. 2nd ed. Oxford;New York:Oxford University Press;2016. p. 407-18.
  20. Carr DB. Pain in HIV/AIDS a major global healthcare problem [Internet]. Washington, D.C.: International Association for the Study of Pain; c2017. Available from: https://www.iasp-pain. org/files/Content/ContentFolders/GlobalYearAgainstPain2/20042005RighttoPainRelief/paininhivaids.pdf.
  21. Almeida MV, Seal PS, Clark RA. Challenges in the management of chronic pain in HIV/AIDS. HIV Clin 2014;26:12-5.
  22. Schutz SG, Robinson-Papp J. HIV-related neuropathy: current perspectives. HIV AIDS (Auckl) 2013;5:243-51.
  23. Merlins JS, Tucker RO, Saag MS, Selwyn PA. The role of palliative care in the current HIV treatment era in developed countries. Top Antivir Med 2013;21:20-6.
  24. Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIVassociated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol 2016;12:662-74. https://doi.org/10.1038/nrneurol.2016.149
  25. Matinella A, Lanzafame M, Bonometti MA, Gajofatto A, Concia E, Vento S, et al. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study. J Neurol 2015;262:1317-27. https://doi.org/10.1007/s00415-015-7713-8
  26. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010;9:425-37. https://doi.org/10.1016/S1474-4422(10)70040-5
  27. Fournier A, Martin-Blondel G, Lechapt-Zalcman E, Dina J, Kazemi A, Verdon R, et al. Immune reconstitution inflammatory syndrome unmasking or worsening AIDS-related progressive multifocal leukoencephalopathy: a literature review. Front Immunol 2017;8:577. https://doi.org/10.3389/fimmu.2017.00577
  28. Arentzen M, Jubt F, Evers S, Hesselmann V, Fiori W, Reichelt D, et al. Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART. Int J Neurosci 2015;125:601-11. https://doi.org/10.3109/00207454.2014.956870
  29. Stuart B. The NHO Medical Guidelines for Non-Cancer Disease and local medical review policy: hospice access for patients with diseases other than cancer. Hosp J 1999;14:139-54.
  30. Local Coverage Determination (LCD) for Hospice - HIV Disease (L31535) [Internet]. Chicago, IL; American Medical Association: c2002-2012. Available from: file:///C:/Users/Yoo/Downloads/Palmetto%20HIV.pdf.
  31. Korean Academy of Medical Sciences. Definitions of the end stage of disease and the last days of life and medical guidance on them. Seoul:Korean Academy of Medical Sciences;2016.
  32. Fox E, Landrum-McNiff K, Zhong Z, Dawson NV, Wu AW, Lynn J. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. JAMA 1999; 282:1638-45. https://doi.org/10.1001/jama.282.17.1638
  33. AIDS: Palliative Care: UNAIDS Technical Update [Internet]. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2000. Available from: http://apps.who.int/medicinedocs/en/d/Jh2930e/2.html.
  34. Kojima Y, Iwasaki N, Yanaga Y, Tanuma J, Koizumi Y, Uehira T, et al. End-of-life care for HIV-infected patients with malignancies: A questionnaire-based survey. Palliat Med 2016; 30:869-76. https://doi.org/10.1177/0269216316635881
  35. Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 2013;34:875-92. https://doi.org/10.1086/672271
  36. Choi JY. Updates on preventing HIV infection. Korean J Med 2016;90:474-80. https://doi.org/10.3904/kjm.2016.90.6.474

Cited by

  1. 진행성 다발성 백질뇌병증을 합병한 HIV/AIDS 환자의 한양방 협진 치료 치험 1례 vol.38, pp.6, 2017, https://doi.org/10.22246/jikm.2017.38.6.1076
  2. HIV-Related Stigma Reduction in the Era of Undetectable Equals Untransmittable: The South Korean Perspective vol.53, pp.4, 2017, https://doi.org/10.3947/ic.2021.0127